HALO logo
halo search icon
Aptevo Therapeutics, Inc.

US$4.56

Price Change Indicator
0.10 (2.36%)
Aptevo Therapeutics, Inc.
APVO · NAS

Aptevo Therapeutics, Inc.

Start Trading APVO for Free

US$4.56

Price Arrow0.10 (2.36%)
20/05/2026 03:59:54 PM
All-CompaniesAll-ConsensusEngulfing Bullish (Realtime)HALO AllHALO Consensus ValueHALO GrowthHammer BullishRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Aptevo Therapeutics, Inc. Overview

APVO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About APVO

icon
icon

Telephone

1.206.838.0500

icon

Address

Suite 1050, 2401 4th Avenue, Seattle, WA 98121

Description

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.

APVO Price Chart

Key Stats

Market Cap

US$5.55M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.8 - 258.01

Trade Value (12mth)

US$1,498,431.00

1 week

-6.71%

1 month

-12.75%

YTD

-52.61%

1 year

-96.75%

All time high

68020400.00

Key Fundamentals

EPS 3 yr Growth

-100.00%

EBITDA Margin

0.00%

Operating Cashflow

-$26m

Free Cash Flow Return

-167.70%

ROIC

-170.10%

Interest Coverage

0.00

Quick Ratio

3.80

Other Data

Shares Outstanding (Fully Diluted)

1m

HALO Sector

Healthcare

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

APVO Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
14 May 26
14 May 26
14 May 26

APVO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-834,044.59-31,458.30-87.27locklocklock
EPS (Fully Diluted)
 $locklocklocklock-834,044.59-31,458.30-87.27locklocklock
Growth
 %locklocklocklock-190.496.299.7locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Aptevo Therapeutics, Inc. (APVO:NAS)?
Halo FAQ
The current share price of Aptevo Therapeutics, Inc. (APVO:NAS) is USD$4.56.
What is the 52-week high share price for Aptevo Therapeutics, Inc. (APVO:NAS)?
Halo FAQ
The 52-week high share price for Aptevo Therapeutics, Inc. (APVO:NAS) is USD$258.01.
What is the 52-week low share price for Aptevo Therapeutics, Inc. (APVO:NAS)?
Halo FAQ
The 52-week low share price for Aptevo Therapeutics, Inc. (APVO:NAS) is USD$3.80.
What is the dividend yield for Aptevo Therapeutics, Inc. (APVO:NAS)?
Halo FAQ
Aptevo Therapeutics, Inc. (APVO:NAS) does not pay a dividend.
What was Aptevo Therapeutics, Inc. (APVO:NAS) last dividend payment?
Halo FAQ
Aptevo Therapeutics, Inc. (APVO:NAS) does not pay a dividend.
What is the franking level for Aptevo Therapeutics, Inc. (APVO:NAS)?
Halo FAQ
Aptevo Therapeutics, Inc. (APVO:NAS) has a franking level of 0.00%.
In which sector is Aptevo Therapeutics, Inc. (APVO:NAS) classified?
Halo FAQ
Aptevo Therapeutics, Inc. (APVO:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial